SureTrader Nadex Advertisement
Home > Boards > US Listed > Medical - Drugs >

Spectrum Pharmaceutecals, Inc. (SPPI)

SPPI RSS Feed
Add SPPI Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/21/2017 7:52:04 AM - Followers: 75 - Board type: Free - Posts Today: 0

http://www.spectrumpharm.com/

http://finance.yahoo.com/q/ks?s=SPPI+Key+Statistics

Company Presentation

http://www.sppirx.com/704-corporate-presentation.html

Spectrum Development Pipeline/Portfolio

Fusilev® (Levoleucovorin) for injection FDA Approved on April 29, 2011 for Use in Patients with Advanced Metastatic Colorectal Cancer and FDA Approved on March 7, 2008 for High-Dose Methotrexate Rescue Therapy in Osteosarcoma.
Zevalin® (ibritumomab tiuxetan), an FDA-Approved, Proprietary, Biological Drug for Indolent Non-Hodgkin's Lymphoma.
Belinostat a novel HDAC inhibitor in late stage clinical development for Peripheral T-cell Lymphoma, and other Solid Tumors (including Carcinoma of Unknown Primary, etc.)
Apaziquone, one of our lead development candidates, is a synthetic bio-reductive prodrug that is being investigated in the treatment of non-invasive bladder cancer, and began two Phase 3 studies in 2007.Spectrum also has three drugs in the Phase 2 stage of development: Ozarelix, for the treatment of prostate cancer and Ortataxel, for the treatment of taxane-refractory tumors.
The Company has three drugs in the Phase 1 stage of development: SPI-1620, an adjunct to chemotherapy, Elsamitrucin, which will target advanced solid tumors and Lucanthone, a chemotherapy sensitizer in the treatment of recurrent, malignant brain tumors.
Other drugs in development include SPI-014, used in the treatment of hyperphosphotemia in end stage renal disease (ESRD), and SPI-205 for chemotherapy induced neuropathy.

Recent News (Zevalin):

http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632354
http://investor.spectrumpharm.com/releasedetail.cfm?ReleaseID=632346

.  

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPPI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
SPPI News: Statement of Changes in Beneficial Ownership (4) 02/22/2017 05:49:58 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 02/22/2017 05:23:17 PM
SPPI News: Statement of Changes in Beneficial Ownership (4) 02/22/2017 05:19:18 PM
SPPI News: Spectrum Pharmaceuticals to Present Corporate Update at the 2017 RBC Capital Markets Global Healthcare Conference on February... 02/16/2017 07:00:00 AM
SPPI News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 11:58:00 AM
PostSubject
#1598   $5, 6, or 7? Where is the SP antihama 02/21/17 07:52:04 AM
#1597   SP at 6.02! trying to get it to antihama 02/16/17 07:27:26 PM
#1596   PR topline data in the next month or antihama 02/16/17 07:22:09 PM
#1595   Spectrum to Present at 2017 RBC Capital Markets antihama 02/16/17 09:03:44 AM
#1594   "Stem cell transplant induces multiple sclerosis remission"; another antihama 02/14/17 04:02:29 PM
#1593   Up 7% today and 9% for the week! antihama 02/10/17 08:23:59 PM
#1592   Correction up 35 cents or 7.38% with strong antihama 02/03/17 09:28:14 AM
#1591   Blackrock still Buying? Back on Jan 24th they antihama 02/02/17 12:06:52 PM
#1590   Another trial showing positive Evomela/melphalan trend should expand. antihama 02/01/17 08:03:56 PM
#1589   Positive Evomela/melphalan trend should expand the Evomela potential antihama 02/01/17 07:39:07 PM
#1588   Interesting, Neulasta biosim application from Novartis was withdrawn antihama 01/28/17 10:29:40 AM
#1587   Leucovorin on backorder. This is the 1st time antihama 01/17/17 11:10:59 AM
#1586   Is Spectrum undervalued? I have to say yes. antihama 01/10/17 09:34:57 AM
#1585   Last winter, I was speculating that Ipsen would antihama 01/09/17 09:43:33 PM
#1584   New Jan Presentation - the Good, the In-Between, antihama 01/09/17 10:47:54 AM
#1583   Up for the day! S/P was down all antihama 01/06/17 04:29:00 PM
#1582   Can successful Poziotinib US P2 trial results for antihama 01/06/17 02:33:05 PM
#1581   Leucovorin on backorder. This is the 1st time antihama 01/05/17 02:01:53 PM
#1580   EVOMELA Received FDA Approval for Two Indications; one antihama 01/04/17 03:58:22 PM
#1579   How well will the Cures Act help SPPI? antihama 12/30/16 07:15:28 PM
#1578   Well. maybe not that excellent of an article. antihama 12/28/16 08:53:56 PM
#1577   Evomela paper comparing stability against conventional PG melphalan antihama 12/19/16 09:38:24 AM
#1576   Translated (and excellent) Zevalin article provided by Kyelion antihama 12/11/16 10:06:26 AM
#1575   Of interest, ASH abstract LBA-1 Comparison of Autologous antihama 12/09/16 08:21:46 AM
#1574   Reissued the poziotinib pre-clinical PR w some differenced antihama 12/08/16 01:58:51 PM
#1573   Here's the Zevalin abstract NOT highlighted by Spectrum antihama 12/07/16 10:05:19 PM
#1572   Here's the Zevalin abstract highlighted by Spectrum. I antihama 12/07/16 10:02:54 PM
#1571   For me the big enchilada in the room antihama 12/07/16 08:41:03 PM
#1570   Senate Clears Bill to Ease FDA Drug and antihama 12/07/16 04:30:08 PM
#1569   Here's the actual abstract 4149 Case Match Control antihama 12/07/16 09:20:54 AM
#1568   ASH abstract 4149 Case Match Control Analysis of antihama 12/07/16 09:09:39 AM
#1567   In March, EVOMELA Received FDA Approval for Two antihama 12/06/16 04:19:24 PM
#1566   Here’s the results from the abstract presented this antihama 12/06/16 12:39:34 PM
#1565   Including yourself, I think that makes two. I antihama 12/05/16 07:58:02 PM
#1564   anti I just want you to know that I Gator_Rasler 12/05/16 11:14:47 AM
#1563   CASI PR on Evomela antihama 12/05/16 10:05:38 AM
#1562   Some thoughts on SABCS 2016 PR antihama 12/05/16 09:51:22 AM
#1561   SABCS 2016 PR antihama 12/05/16 09:04:11 AM
#1560   The Pralatrexate - Romidepsin Doublet: A Well Tolerated antihama 12/02/16 08:28:50 AM
#1559   Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th antihama 12/02/16 08:14:41 AM
#1558   P2 Immune Disorder HSCT Protocol NCT01821781 antihama 11/29/16 03:36:52 PM
#1557   Pretty detailed description of the trial in clinical antihama 11/29/16 02:59:45 PM
#1556   Another ASCT MS study using melphalan antihama 11/29/16 02:52:39 PM
#1555   Essentially the patient is getting 2 myleeoablative treatments antihama 11/29/16 02:40:16 PM
#1554   Zevalin Posting from Kyelion 6 days ago on Yahoo antihama 11/23/16 01:36:29 PM
#1553   No new bladder cancer tool in the shed, antihama 11/18/16 04:14:17 PM
#1552   BINGO!!! As I was suspecting the share price antihama 11/18/16 08:07:11 AM
#1551   Poziotinib PR issued today. While not the SABCS antihama 11/17/16 07:57:37 AM
#1550   Another 3% down today. While I think the antihama 11/16/16 05:11:25 PM
#1549   Based on what's happening to the stock price, antihama 11/15/16 02:00:50 PM
PostSubject